The pancreas is a vital gland located deep within the abdomen, positioned behind the stomach and close to several major blood vessels, which makes it both essential for bodily function and difficult to examine directly. It performs two major roles: an exocrine function, where it produces digestive enzymes that help break down fats, proteins, and carbohydrates in the small intestine, and an endocrine function, where it releases hormones such as insulin and glucagon into the bloodstream to regulate blood sugar levels. Because of this dual role, damage to the pancreas can affect both digestion and metabolic balance simultaneously. When abnormal cells begin to grow uncontrollably in this organ, they form what is known as pancreatic cancer—specifically, a group of diseases that often behave aggressively and are difficult to detect in early stages. Pancreatic cancer is relatively less common compared to other cancers, but it is disproportionately deadly because it is usually diagnosed late, after it has already spread beyond the pancreas. In countries like the UK, it ranks among the top ten most common cancers, yet it has one of the lowest survival rates. This is largely because early symptoms are vague, easily mistaken for other digestive or gastrointestinal conditions, and often ignored until the disease progresses significantly. Its hidden location within the body, combined with the lack of reliable early screening tools for the general population, contributes to its reputation as a “silent” cancer that develops unnoticed for months or even years.

The development of pancreatic cancer is a complex process influenced by genetic, environmental, and lifestyle factors, though in many cases the exact cause remains unclear. The majority of cases originate in the ductal cells of the pancreas, leading to a form known as pancreatic ductal adenocarcinoma, which is responsible for most diagnoses and has a particularly aggressive course. This type of cancer begins when mutations occur in the DNA of pancreatic cells, causing them to divide uncontrollably and avoid normal cell death mechanisms. Over time, these abnormal cells form tumors that can invade nearby tissues and spread to distant organs such as the liver, lungs, or peritoneum. Several risk factors increase the likelihood of developing the disease. Smoking is one of the most significant, as tobacco chemicals can directly damage pancreatic tissue and accelerate genetic mutations. Chronic pancreatitis, a long-term inflammation of the pancreas often linked to alcohol use or genetic conditions, also increases risk by repeatedly injuring the tissue and forcing constant repair cycles. Obesity and a diet high in processed foods and red meat have been associated with increased incidence, likely due to chronic inflammation and metabolic stress. Age is another major factor, with most cases occurring in individuals over 60. Additionally, a sudden onset of diabetes in later life can sometimes be both a risk factor and an early warning sign, as tumor growth may interfere with insulin production. Inherited genetic mutations, such as those affecting BRCA1 and BRCA2 genes, also contribute to a smaller but important subset of cases.

Symptoms of pancreatic cancer are often subtle in the early stages, which makes early detection extremely challenging. As the disease progresses, symptoms become more noticeable but are still frequently mistaken for less serious gastrointestinal issues. One of the most common symptoms is abdominal pain, often located in the upper abdomen and sometimes radiating to the back. This pain may initially come and go but tends to become more persistent as the tumor grows and presses on surrounding nerves and organs. Another significant symptom is jaundice, which presents as yellowing of the skin and eyes. This occurs when a tumor in the head of the pancreas blocks the bile duct, preventing bile from properly draining into the intestines and causing a buildup of bilirubin in the blood. Patients may also experience severe and unexplained weight loss, often due to a combination of reduced appetite, metabolic changes caused by the tumor, and impaired digestion. Because the pancreas is responsible for producing digestive enzymes, its dysfunction can lead to fatty or oily stools, a condition known as steatorrhea, where the body is unable to properly absorb dietary fats. Additional symptoms may include nausea, changes in bowel habits such as diarrhea or constipation, generalized fatigue, and itching of the skin due to bile accumulation. In some cases, blood clots or new-onset diabetes may also appear as secondary effects of the disease, further complicating diagnosis.

Diagnosing pancreatic cancer typically requires a combination of imaging tests, laboratory investigations, and sometimes tissue sampling. Because symptoms are non-specific, doctors often begin with imaging techniques such as CT scans or MRI scans, which can provide detailed pictures of the pancreas and surrounding structures. These scans help identify the size, location, and possible spread of a tumor. Endoscopic ultrasound (EUS) is another important diagnostic tool, where a small ultrasound probe is passed through the digestive tract to obtain high-resolution images of the pancreas from within the body. EUS also allows for fine-needle biopsy, where a small tissue sample is taken from the suspected tumor and examined under a microscope to confirm the presence of cancer cells. Blood tests may also be used, particularly those measuring tumor markers such as CA19-9, which is often elevated in pancreatic cancer. However, this marker is not specific and can also rise in other conditions such as gallstones or liver disease, meaning it cannot be used alone for diagnosis. Liver function tests may reveal abnormalities if the bile duct is blocked. Despite these tools, early diagnosis remains difficult, and many cases are only identified after the cancer has reached an advanced stage or spread beyond the pancreas, limiting treatment options.

Treatment for pancreatic cancer depends on the stage at which it is diagnosed, the location of the tumor, and the patient’s overall health. Surgery offers the best chance of long-term survival, but only a small percentage of patients are eligible because the disease is often detected too late. One of the most common surgical procedures is the Whipple operation, which involves removing the head of the pancreas along with parts of the small intestine, bile duct, and sometimes part of the stomach. For tumors located in other parts of the pancreas, partial or total pancreatectomy may be performed. In cases where surgery is not possible, chemotherapy is the primary treatment option, using drugs designed to slow cancer growth, shrink tumors, or relieve symptoms. Radiation therapy may also be used in combination with chemotherapy to target cancer cells more precisely. In recent years, targeted therapies and immunotherapy have emerged as promising approaches, aiming to attack specific genetic mutations or enhance the body’s immune response against cancer cells. However, these treatments are still being refined and are not suitable for all patients. Palliative care also plays a crucial role, focusing on improving quality of life by managing pain, digestive issues, and emotional distress. This supportive approach is often integrated alongside medical treatments to ensure patient comfort throughout the course of the disease.

The overall prognosis for pancreatic cancer remains challenging, primarily due to late diagnosis and its aggressive nature. Survival rates are significantly higher when the disease is detected early and surgically removed, but this is rare. For most patients diagnosed at an advanced stage, treatment focuses on prolonging life and improving quality rather than achieving a cure. This reality has driven increased efforts in research, particularly in the areas of early detection, genetic profiling, and personalized medicine. Scientists are exploring new biomarkers that could allow earlier identification of the disease, as well as advanced imaging techniques that may detect tumors before symptoms appear. Prevention also plays an important role, even though not all risk factors are controllable. Avoiding smoking, maintaining a healthy weight, limiting alcohol consumption, and managing chronic conditions such as diabetes and pancreatitis can reduce risk. Public awareness is equally important, as recognizing persistent or unusual symptoms can lead to earlier medical evaluation. While pancreatic cancer remains one of the most difficult cancers to treat, ongoing advances in research and medical technology continue to offer hope that earlier detection and more effective therapies will improve outcomes in the future.